Risk Analysis: A generalized Hazop methodology state-of-the-art, applications, and perspective in the process industry
| Autor(a) principal: | |
|---|---|
| Data de Publicação: | 2018 |
| Outros Autores: | , , |
| Tipo de documento: | Artigo |
| Idioma: | eng por spa |
| Título da fonte: | Vigilância Sanitária em Debate |
| Texto Completo: | https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/990 |
Resumo: | Introduction: The Hazard and Operability Study is considered a feasible tool to assess risks, where complex technologies, require new strategies to guarantee efficiency, safety, and quality of products. Objective: To perform a Hazop publications review, to establish the state of the art, current procedures and perspectives in the pharmaceutical industry. Method: Hazop methodology and improvements to satisfy actual needs were structured. Subsequently, its application and integration with other risk tools, and experts systems, were analyzed to define the current approach and future perspectives. Results: The review allowed the understanding where models, simulations and specialized software offered adequate support to assess risk in current complex processes. In addition, an efficient definition of causes and consequences depends of expert systems, where simulations acquire experience through the creation of databases, reducing the need of specific process knowledge, which is a typical limitation of the conventional Hazop methodology. Conclusions: A review of the Hazop stateof- the-art highlighted the importance to assess risks within the process industry. However, the use of new technologies designed to meet regulatory affairs to guarantee safety and quality principles would require the ongoing improvement of the Hazop methodology, restricting the dependence of specialists, and increasing the use of expert systems. |
| id |
FIOCRUZ-9_6a2c74e925672c215e781acfeee40e5a |
|---|---|
| oai_identifier_str |
oai:ojs.visaemdebate.incqs.fiocruz.br:article/990 |
| network_acronym_str |
FIOCRUZ-9 |
| network_name_str |
Vigilância Sanitária em Debate |
| repository_id_str |
|
| spelling |
Risk Analysis: A generalized Hazop methodology state-of-the-art, applications, and perspective in the process industryAnálisis de riesgo: una metodología de Hazop generalizada del estado del arte, aplicaciones y perspectiva en la industria de procesosAnálise de Risco: estado da arte da metodologia Hazop generalizada, aplicações e perspectivas na indústria de processosHazopRisk AssessmentProcess Hazard AnalysisDeviationHazardHazopEvaluación de riesgosAnálisis de Riesgos del ProcesoDesviaciónRiesgosHazopAvaliação de RiscoAnálise de Perigo do ProcessoDesvioPerigoIntroduction: The Hazard and Operability Study is considered a feasible tool to assess risks, where complex technologies, require new strategies to guarantee efficiency, safety, and quality of products. Objective: To perform a Hazop publications review, to establish the state of the art, current procedures and perspectives in the pharmaceutical industry. Method: Hazop methodology and improvements to satisfy actual needs were structured. Subsequently, its application and integration with other risk tools, and experts systems, were analyzed to define the current approach and future perspectives. Results: The review allowed the understanding where models, simulations and specialized software offered adequate support to assess risk in current complex processes. In addition, an efficient definition of causes and consequences depends of expert systems, where simulations acquire experience through the creation of databases, reducing the need of specific process knowledge, which is a typical limitation of the conventional Hazop methodology. Conclusions: A review of the Hazop stateof- the-art highlighted the importance to assess risks within the process industry. However, the use of new technologies designed to meet regulatory affairs to guarantee safety and quality principles would require the ongoing improvement of the Hazop methodology, restricting the dependence of specialists, and increasing the use of expert systems.Introducción: El Estudio de Riesgos y Operabilidad se considera una herramienta factible para evaluar los riesgos, cuando las tecnologías complejas requieren nuevas estrategias para garantizar la eficiencia, la seguridad y la calidad de los productos. Objetivo: realizar una revisión de las publicaciones de Hazop, para establecer el estado del arte, los procedimientos actuales y las perspectivas en la industria farmacéutica. Método: fue estructurada la metodología Hazop y las mejoras para satisfacer las necesidades reales. Posteriormente, se analizó su aplicación e integración con otras herramientas de riesgo y sistemas de expertos para definir el enfoque actual y las perspectivas futuras. Resultados: la revisión permitió comprender dónde los modelos, las simulaciones y el software especializado ofrecían el soporte adecuado para evaluar el riesgo en los procesos complejos actuales. Además, una definición eficiente de causas y consecuencias depende de los sistemas expertos, donde las simulaciones adquieren experiencia a través de la creación de bases de datos, lo que reduce la necesidad de un conocimiento específico del proceso, que es una limitación típica de la metodología convencional Hazop. Conclusiones: una revisión del estado del arte de Hazop resaltó la importancia de evaluar los riesgos dentro de la industria de procesos. Sin embargo, el uso de nuevas tecnologías diseñadas para cumplir con los asuntos regulatorios para garantizar los principios de seguridad y calidad requeriría la mejora continua de la metodología Hazop, restringiendo la dependencia de especialistas y aumentando el uso de sistemas expertos.Título PT: Análise de Risco: estado da arte da metodologia Hazop generalizada, aplicações e perspectivas na indústria de processos Introdução: O Estudo de Perigos e Operabilidade (Hazop) é considerado uma ferramenta para avaliação de riscos, na qual tecnologias complexas exigem novas estratégias para garantir a eficiência, a segurança e a qualidade dos produtos. Objetivo: Realizar uma revisão de publicações do Hazop, para estabelecer o estado da arte, os procedimentos e as suas perspectivas na indústria farmacêutica. Método: O procedimento Hazop e suas adequações para satisfazer as necessidades atuais foram estruturados. Posteriormente, aplicações e integração com outras ferramentas de risco e sistemas expertos foram analisadas para definir a abordagem atual e perspectivas futuras. Resultados: A revisão permitiu a compreensão de que modelos, simulações e software especializado oferecem suporte para avaliar riscos em processos complexos. Adicionalmente, a correta definição de causas e consequências depende do uso de sistemas expertos, cujas simulações adquirem experiência através da criação de bancos de dados, reduzindo a necessidade de conhecimento específico do processo, que é uma limitação da metodologia Hazop convencional. Conclusões: A revisão do estado da arte do Hazop destacou a importância de avaliar riscos dentro da indústria de processos. No entanto, novas tecnologias utilizadas para atender quesitos regulatórios de segurança e qualidade precisam da melhoria contínua da metodologia Hazop, reduzindo a dependência de especialista por meio do uso de sistemas especializados.Instituto Nacional de Controle de Qualidade em Saúde2018-05-30info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion"Peer-reviewed article""Artículo revisado por pares""Artigo avaliado pelos pares"application/pdfapplication/pdfapplication/pdfhttps://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/99010.22239/2317-269X.00990Health Surveillance under Debate: Society, Science & Technology ; Vol. 6 No. 2 (2018): May; 106-121Vigilancia en Salud en Debate: Sociedad, Ciencia y Tecnología; Vol. 6 Núm. 2 (2018): Puede; 106-121Vigil Sanit Debate, Rio de Janeiro; v. 6 n. 2 (2018): Maio; 106-1212317-269Xreponame:Vigilância Sanitária em Debateinstname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZengporspahttps://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/990/442https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/990/1065https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/990/481Copyright (c) 2018 Vigilância Sanitária em Debate: Sociedade, Ciência & Tecnologia (Health Surveillance under Debate: Society, Science & Technology) – Visa em Debatehttps://creativecommons.org/licenses/by-nc-nd/4.0info:eu-repo/semantics/openAccessde la O Herrera, Miguel AngelLuna, Aderval Severinoda Costa, Antonio Carlos AugustoLemes, Elezer Monte Blanco2023-06-27T15:10:49Zoai:ojs.visaemdebate.incqs.fiocruz.br:article/990Revistahttps://visaemdebate.incqs.fiocruz.br/index.php/visaemdebatePUBhttps://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/oaiincqs.visaemdebate@fiocruz.br || gisele.neves@fiocruz.br2317-269X2317-269Xopendoar:2023-06-27T15:10:49Vigilância Sanitária em Debate - Fundação Oswaldo Cruz (FIOCRUZ)false |
| dc.title.none.fl_str_mv |
Risk Analysis: A generalized Hazop methodology state-of-the-art, applications, and perspective in the process industry Análisis de riesgo: una metodología de Hazop generalizada del estado del arte, aplicaciones y perspectiva en la industria de procesos Análise de Risco: estado da arte da metodologia Hazop generalizada, aplicações e perspectivas na indústria de processos |
| title |
Risk Analysis: A generalized Hazop methodology state-of-the-art, applications, and perspective in the process industry |
| spellingShingle |
Risk Analysis: A generalized Hazop methodology state-of-the-art, applications, and perspective in the process industry de la O Herrera, Miguel Angel Hazop Risk Assessment Process Hazard Analysis Deviation Hazard Hazop Evaluación de riesgos Análisis de Riesgos del Proceso Desviación Riesgos Hazop Avaliação de Risco Análise de Perigo do Processo Desvio Perigo |
| title_short |
Risk Analysis: A generalized Hazop methodology state-of-the-art, applications, and perspective in the process industry |
| title_full |
Risk Analysis: A generalized Hazop methodology state-of-the-art, applications, and perspective in the process industry |
| title_fullStr |
Risk Analysis: A generalized Hazop methodology state-of-the-art, applications, and perspective in the process industry |
| title_full_unstemmed |
Risk Analysis: A generalized Hazop methodology state-of-the-art, applications, and perspective in the process industry |
| title_sort |
Risk Analysis: A generalized Hazop methodology state-of-the-art, applications, and perspective in the process industry |
| author |
de la O Herrera, Miguel Angel |
| author_facet |
de la O Herrera, Miguel Angel Luna, Aderval Severino da Costa, Antonio Carlos Augusto Lemes, Elezer Monte Blanco |
| author_role |
author |
| author2 |
Luna, Aderval Severino da Costa, Antonio Carlos Augusto Lemes, Elezer Monte Blanco |
| author2_role |
author author author |
| dc.contributor.author.fl_str_mv |
de la O Herrera, Miguel Angel Luna, Aderval Severino da Costa, Antonio Carlos Augusto Lemes, Elezer Monte Blanco |
| dc.subject.por.fl_str_mv |
Hazop Risk Assessment Process Hazard Analysis Deviation Hazard Hazop Evaluación de riesgos Análisis de Riesgos del Proceso Desviación Riesgos Hazop Avaliação de Risco Análise de Perigo do Processo Desvio Perigo |
| topic |
Hazop Risk Assessment Process Hazard Analysis Deviation Hazard Hazop Evaluación de riesgos Análisis de Riesgos del Proceso Desviación Riesgos Hazop Avaliação de Risco Análise de Perigo do Processo Desvio Perigo |
| description |
Introduction: The Hazard and Operability Study is considered a feasible tool to assess risks, where complex technologies, require new strategies to guarantee efficiency, safety, and quality of products. Objective: To perform a Hazop publications review, to establish the state of the art, current procedures and perspectives in the pharmaceutical industry. Method: Hazop methodology and improvements to satisfy actual needs were structured. Subsequently, its application and integration with other risk tools, and experts systems, were analyzed to define the current approach and future perspectives. Results: The review allowed the understanding where models, simulations and specialized software offered adequate support to assess risk in current complex processes. In addition, an efficient definition of causes and consequences depends of expert systems, where simulations acquire experience through the creation of databases, reducing the need of specific process knowledge, which is a typical limitation of the conventional Hazop methodology. Conclusions: A review of the Hazop stateof- the-art highlighted the importance to assess risks within the process industry. However, the use of new technologies designed to meet regulatory affairs to guarantee safety and quality principles would require the ongoing improvement of the Hazop methodology, restricting the dependence of specialists, and increasing the use of expert systems. |
| publishDate |
2018 |
| dc.date.none.fl_str_mv |
2018-05-30 |
| dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion "Peer-reviewed article" "Artículo revisado por pares" "Artigo avaliado pelos pares" |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.uri.fl_str_mv |
https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/990 10.22239/2317-269X.00990 |
| url |
https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/990 |
| identifier_str_mv |
10.22239/2317-269X.00990 |
| dc.language.iso.fl_str_mv |
eng por spa |
| language |
eng por spa |
| dc.relation.none.fl_str_mv |
https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/990/442 https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/990/1065 https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/990/481 |
| dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by-nc-nd/4.0 info:eu-repo/semantics/openAccess |
| rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-nd/4.0 |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
application/pdf application/pdf application/pdf |
| dc.publisher.none.fl_str_mv |
Instituto Nacional de Controle de Qualidade em Saúde |
| publisher.none.fl_str_mv |
Instituto Nacional de Controle de Qualidade em Saúde |
| dc.source.none.fl_str_mv |
Health Surveillance under Debate: Society, Science & Technology ; Vol. 6 No. 2 (2018): May; 106-121 Vigilancia en Salud en Debate: Sociedad, Ciencia y Tecnología; Vol. 6 Núm. 2 (2018): Puede; 106-121 Vigil Sanit Debate, Rio de Janeiro; v. 6 n. 2 (2018): Maio; 106-121 2317-269X reponame:Vigilância Sanitária em Debate instname:Fundação Oswaldo Cruz (FIOCRUZ) instacron:FIOCRUZ |
| instname_str |
Fundação Oswaldo Cruz (FIOCRUZ) |
| instacron_str |
FIOCRUZ |
| institution |
FIOCRUZ |
| reponame_str |
Vigilância Sanitária em Debate |
| collection |
Vigilância Sanitária em Debate |
| repository.name.fl_str_mv |
Vigilância Sanitária em Debate - Fundação Oswaldo Cruz (FIOCRUZ) |
| repository.mail.fl_str_mv |
incqs.visaemdebate@fiocruz.br || gisele.neves@fiocruz.br |
| _version_ |
1797042044823142400 |